CapWealth Advisors LLC Buys 23,877 Shares of CVS Health Corporation (NYSE:CVS)

CapWealth Advisors LLC increased its holdings in CVS Health Corporation (NYSE:CVS - Free Report) by 7.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 361,854 shares of the pharmacy operator's stock after acquiring an additional 23,877 shares during the period. CVS Health comprises 2.7% of CapWealth Advisors LLC's investment portfolio, making the stock its 11th biggest holding. CapWealth Advisors LLC's holdings in CVS Health were worth $24,516,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Proficio Capital Partners LLC purchased a new stake in shares of CVS Health in the fourth quarter valued at about $5,544,000. OFI Invest Asset Management purchased a new stake in shares of CVS Health in the fourth quarter valued at about $65,000. Sowell Financial Services LLC raised its holdings in shares of CVS Health by 17.4% in the fourth quarter. Sowell Financial Services LLC now owns 38,370 shares of the pharmacy operator's stock valued at $1,722,000 after purchasing an additional 5,689 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of CVS Health by 21.8% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 318,089 shares of the pharmacy operator's stock valued at $14,279,000 after purchasing an additional 56,895 shares during the last quarter. Finally, Daiwa Securities Group Inc. raised its holdings in shares of CVS Health by 7.8% in the fourth quarter. Daiwa Securities Group Inc. now owns 165,314 shares of the pharmacy operator's stock valued at $7,421,000 after purchasing an additional 11,955 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.

Insider Activity at CVS Health

In other news, Director Guy P. Sansone acquired 1,570 shares of the business's stock in a transaction dated Thursday, June 5th. The stock was bought at an average cost of $63.70 per share, for a total transaction of $100,009.00. Following the completion of the transaction, the director owned 12,007 shares of the company's stock, valued at $764,845.90. The trade was a 15.04% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 1.22% of the company's stock.

Analysts Set New Price Targets

Several analysts have recently commented on the stock. Wall Street Zen upgraded shares of CVS Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Wells Fargo & Company restated an "overweight" rating and set a $84.00 price objective (up previously from $76.00) on shares of CVS Health in a report on Tuesday, May 6th. Jefferies Financial Group raised their price objective on shares of CVS Health from $74.00 to $80.00 and gave the stock a "buy" rating in a report on Monday, June 30th. Cowen restated a "buy" rating on shares of CVS Health in a report on Monday, May 5th. Finally, Morgan Stanley restated an "overweight" rating on shares of CVS Health in a report on Tuesday, April 15th. Two investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $75.06.

CVS Health Stock Performance

Shares of CVS traded down $1.08 during trading hours on Friday, hitting $64.54. The company's stock had a trading volume of 2,150,631 shares, compared to its average volume of 10,764,041. The company has a market cap of $81.64 billion, a price-to-earnings ratio of 15.41, a PEG ratio of 0.95 and a beta of 0.57. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.82 and a quick ratio of 0.63. The business has a 50 day simple moving average of $65.10 and a two-hundred day simple moving average of $62.08. CVS Health Corporation has a 52-week low of $43.56 and a 52-week high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The company had revenue of $94.59 billion during the quarter, compared to analyst estimates of $93.07 billion. During the same period last year, the business earned $1.31 earnings per share. CVS Health's revenue was up 7.0% compared to the same quarter last year. On average, equities analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 1st. Stockholders of record on Tuesday, July 22nd will be given a $0.665 dividend. The ex-dividend date of this dividend is Tuesday, July 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.12%. CVS Health's dividend payout ratio (DPR) is currently 63.48%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.